The reversal has also impacted CRO’s market performance. The token’s price has fallen 8% this week, dropping to around $0.079, far below its peak value of $0.9698 in November 2021.

Icon, a global CRO power, forecast revenues for 2022 to fall within a range of $7.7 billion to $8.05 billion, which equates to growth of between 43% to 46% versus 2021 numbers. The company said ...

New year, new Veeda. | New year, new Veeda. The India-based CRO formerly known as Veeda Group has kicked off 2025 with a brand makeover.

Canary Capital has filed for a staked CRO ETF offering regulated exposure to Crypto.com’s native token without direct ownership. The ETF will track CRO’s price and generate yield by staking a ...

Of all therapeutic areas, oncology had the largest share of both markets in 2024, representing 30.66% of the CRO market and 35.1% of the clinical trial market, according to Research and Markets ...

Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial ...

Sygnature Discovery completes major enhancement of high-throughput chemistry facilities following £1 million investment: Nottingham, UK Friday, July 25, 2025, 16:00 Hrs [IST] Syg ...

Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...